Fatty liver disease in children: Eat now pay later

Hepatology International

Volumn 4, Issue 1, 2010, Pages 375-385

  De Bruyne, Ruth M L ^a   Fitzpatrick, Emer ^b   Dhawan, Anil ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Children; Nonalcoholic fatty liver disease (NAFLD); Nonalcoholic steatohepatitis (NASH); Obesity

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BIOLOGICAL MARKER; METFORMIN; PLACEBO; URSODEOXYCHOLIC ACID;

CHILDHOOD DISEASE; CLINICAL TRIAL; CYTOKINE PRODUCTION; DIAGNOSTIC IMAGING; DIET THERAPY; DISEASE COURSE; ETHNIC DIFFERENCE; FATTY LIVER; GENETIC ASSOCIATION; GENETIC RISK; HEPATITIS; HUMAN; LIFESTYLE MODIFICATION; LIVER BIOPSY; LIVER FIBROSIS; LIVER HISTOLOGY; MEDICAL HISTORY; NON INVASIVE MEASUREMENT; NONALCOHOLIC FATTY LIVER; OBESITY; OXIDATIVE STRESS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 77949653961     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-009-9160-z     Document Type: Review

References (90)

1. R Ludwig 1980 Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed Mayo Clin Proc 55 434 438 1:STN:280:DyaL3c3gvVeqtQ%3D%3D 7382552
2. JR Moran FK Ghishan SA Halter HL Greene 1983 Steatohepatitis in obese children: a cause of chronic liver dysfunction Am J Gastroenterol 78 374 377 1:STN:280:DyaL3s3ivVSltA%3D%3D 6859017
3. JJ Reilly 2006 Diagnostic accuracy of the BMI for age in paediatrics Int J Obes 30 595 597 10.1038/sj.ijo.0803301 1:STN:280:DC%2BD287nsFymtQ%3D%3D
4. E Stamatakis P Primatesta S Chinn R Rona E Falascheti 2005 Overweight and obesity trends from 1974 to 2003 in English children: what is the role of socioeconomic factors? Arch Dis Child 90 999 1004 10.1136/adc.2004.068932 1:STN:280:DC%2BD2MrgsVehug%3D%3D 15956046 (Pubitemid 41406602)
5. CL Ogden KM Flegal MD Carroll CL Johnson 2002 Prevalence and trends in overweight among US children and adolescents, 1999-2000 JAMA 288 1728 1732 10.1001/jama.288.14.1728 12365956
6. HM Patton C Sirlin C Behling M Middleton JB Schwimmer JE Lavine 2006 Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research J Pediatr Gastroenterol Nutr 43 413 427 10.1097/01.mpg.0000239995.58388.56 17033514 (Pubitemid 44568999)
7. D Prati E Taioli A Zanella E Della Torre S Butelli E Del Vecchio, et al. 2002 Updated definitions of healthy ranges for serum alanine aminotransferase levels Ann Intern Med 137 1 10 1:CAS:528:DC%2BD38Xls1entbc%3D 12093239
8. M Rashid EA Roberts 2000 Nonalcoholic steatohepatitis in children J Pediatr Gastroenterol Nutr 30 48 53 10.1097/00005176-200001000-00017 1:STN:280:DC%2BD3c%2FpsVWgtw%3D%3D 10630439 (Pubitemid 30349945)
9. JB Schwimmer C Behling R Newbury R Deutsch C Nievergelt NJ Schork, et al. 2005 Histopathology of pediatric nonalcoholic fatty liver disease Hepatology 42 641 649 10.1002/hep.20842 16116629 (Pubitemid 41233657)
10. A Fraser MP Longnecker DA Lawlor 2007 Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004 Gastroenterology 133 1814 1820 10.1053/j.gastro.2007.08.077 1:CAS:528: DC%2BD1cXnt1Kqsw%3D%3D 18054554 (Pubitemid 350186161)
11. K Tominaga JH Kurata YK Chen E Fujimoto S Miyagawa I Abe, et al. 1995 Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey Dig Dis Sci 40 2002 2009 10.1007/BF02208670 1:STN:280:DyaK28%2FivFamsw%3D%3D 7555456
12. HS Park JH Han KM Choi SM Kim 2005 Relation between elevated serum alanine aminotransferase and metabolic syndrome in Korean adolescents Am J Clin Nutr 82 1046 1051 1:CAS:528:DC%2BD2MXht1ektLbK 16280437
13. JB Schwimmer R Deutsch T Kahen JE Lavine C Stanley C Behling 2006 Prevalence of fatty liver in children and adolescents Pediatrics 118 1388 1393 10.1542/peds.2006-1212 17015527 (Pubitemid 46393782)
14. RS Strauss SE Barlow WH Dietz 2000 Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents J Pediatr 136 727 733 10.1067/mpd.2000.102940 1:CAS:528:DC%2BD3cXkslynsrc%3D 10839867
15. RE Quiros-Tejeira CA Rivera TT Ziba N Mehta CW Smith NF Butte 2007 Risk for nonalcoholic fatty liver disease in Hispanic youth with BMI > or =95th percentile J Pediatr Gastroenterol Nutr 44 228 236 10.1097/MPG.0b013e31802d4acc 1:CAS:528:DC%2BD2sXptFegtw%3D%3D 17255837 (Pubitemid 46175078)
16. JB Schwimmer N McGreal R Deutsch MJ Finegold JE Lavine 2005 Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents Pediatrics 115 e561 e565 10.1542/peds.2004-1832 15867021 (Pubitemid 43843214)
17. JB Schwimmer R Deutsch JB Rauch C Behling R Newbury JE Lavine 2003 Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease J Pediatr 143 500 505 10.1067/S0022-3476(03)00325-1 14571229 (Pubitemid 37352510)
18. IR Willner B Waters SR Patil A Reuben J Morelli CA Riely 2001 Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease Am J Gastroenterol 96 2957 2961 10.1111/j.1572-0241.2001.04667.x 1:STN:280:DC%2BD3MnjvVWqsQ%3D%3D 11693332
19. Carter-Kent C, Feldstein AE. Non-alcoholic steatohepatitis over multiple generations. Dig Dis Sci 2009 (in press)
20. S Romeo J Kozlitina C Xing A Pertsemlidis D Cox LA Pennacchio, et al. 2008 Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease Nat Genet 40 1461 1465 10.1038/ng.257 1:CAS:528:DC%2BD1cXhsVWgsrrP 18820647
21. L Carulli I Canedi S Rondinella S Lombardini D Ganazzi S Fargion, et al. 2009 Genetic polymorphisms in non-alcoholic fatty liver disease: interleukin-6-174G/C polymorphism is associated with non-alcoholic steatohepatitis Dig Liver Dis 41 823 828 10.1016/j.dld.2009.03.005 1:CAS:528:DC%2BC3cXitFGhsrg%3D 19403348
22. K Tokushige M Takakura N Tsuchiya-Matsushita M Taniai E Hashimoto K Shiratori 2007 Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosis J Hepatol 46 1104 1110 10.1016/j.jhep.2007.01.028 1:CAS:528:DC%2BD2sXkvFGjsbk%3D 17395331 (Pubitemid 46669735)
23. L Miele G Beale G Patman V Nobili J Leathart A Grieco, et al. 2008 The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease Gastroenterology 135 282 291 10.1053/j.gastro.2008.04.004 1:CAS:528:DC%2BD1cXps1Wlur4%3D 18515091
24. M Ricchi MR Odoardi L Carulli C Anzivino S Ballestri A Pinetti, et al. 2009 Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes J Gastroenterol Hepatol 24 830 840 10.1111/j.1440-1746.2008.05733.x 1:CAS:528:DC%2BD1MXotFOmtLc%3D 19207680
25. X Ouyang P Cirillo Y Sautin S McCall JL Bruchette AM Diehl, et al. 2008 Fructose consumption as a risk factor for non-alcoholic fatty liver disease J Hepatol 48 993 999 10.1016/j.jhep.2008.02.011 1:CAS:528:DC%2BD1cXlvVSksLk%3D 18395287
26. G Musso R Gambino F De Michieli M Cassader M Rizzetto M Durazzo, et al. 2003 Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis Hepatology 37 909 916 10.1053/jhep.2003.50132 1:CAS:528:DC%2BD3sXjt1WlurY%3D 12668986 (Pubitemid 36397404)
27. M Manco M Marcellini R Devito D Comparcola MR Sartorelli V Nobili 2008 Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis Int J Obes 32 381 387 10.1038/sj.ijo.0803711 1:STN:280:DC%2BD1c7itVequw%3D%3D
28. A Franzese P Vajro A Argenziano A Puzziello MP Iannucci Saviano MC, et al. 1997 Liver involvement in obese children. Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population Dig Dis Sci 42 1428 1432 10.1023/A:1018850223495 1:STN:280:DyaK2szovVyjug%3D%3D 9246041 (Pubitemid 27339358)
29. S Saadeh ZM Younossi EM Remer T Gramlich JP Ong M Hurley, et al. 2002 The utility of radiological imaging in nonalcoholic fatty liver disease Gastroenterology 123 745 750 10.1053/gast.2002.35354 12198701
30. M Fishbein F Castro S Cheruku S Jain B Webb T Gleason, et al. 2005 Hepatic MRI for fat quantitation: its relationship to fat morphology, diagnosis, and ultrasound J Clin Gastroenterol 39 619 625 10.1097/00004836-200508000-00012 16000931 (Pubitemid 41061269)
31. G Radetti W Kleon J Stuefer K Pittschieler 2006 Non-alcoholic fatty liver disease in obese children evaluated by magnetic resonance imaging Acta Paediatr 95 833 837 10.1080/08035250500449890 16801180 (Pubitemid 44261742)
32. A Wieckowska AJ McCullough AE Feldstein 2007 Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future Hepatology 46 582 589 10.1002/hep.21768 1:CAS:528:DC%2BD2sXhtVSisbzE 17661414 (Pubitemid 47344794)
33. AD Baldridge AR Perez-Atayde F Graeme-Cook L Higgins JE Lavine 1995 Idiopathic steatohepatitis in childhood: a multicenter retrospective study J Pediatr 127 700 704 10.1016/S0022-3476(95)70156-7 1:STN:280: DyaK28%2FmtVyquw%3D%3D 7472819
34. EA Roberts 2007 Non-alcoholic steatohepatitis in children Clin Liver Dis 11 155 172 10.1016/j.cld.2007.02.008 17544977 (Pubitemid 46830976)
35. DE Kleiner EM Brunt M Van Natta C Behling MJ Contos OW Cummings, et al. 2005 Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 1313 1321 10.1002/hep.20701 15915461 (Pubitemid 40770284)
36. Feldstein AE, Charatcharoenwitthaya P, Treeprasertsuk S, Benson JT, Enders FB, Angulo P. The natural history of nonalcoholic fatty liver disease in children: a follow-up study for up to 20-years. Gut 2009 (in press)
37. IN Guha J Parkes PR Roderick S Harris WM Rosenberg 2006 Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease Gut 55 1650 1660 10.1136/gut.2006.091454 1:CAS:528:DC%2BD28Xht1GkurjO 17047111 (Pubitemid 44629217)
38. I Ciba K Widhalm 2007 The association between non-alcoholic fatty liver disease and insulin resistance in 20 obese children and adolescents Acta Paediatr 96 109 112 10.1111/j.1651-2227.2007.00031.x 17187615 (Pubitemid 46307394)
39. DF Chan AM Li WC Chu MH Chan EM Wong EK Liu, et al. 2004 Hepatic steatosis in obese Chinese children Int J Obes Relat Metab Disord 28 1257 1263 10.1038/sj.ijo.0802734 1:STN:280:DC%2BD2cvls1WmsA%3D%3D 15278103 (Pubitemid 39389582)
40. CP Day OF James 1998 Steatohepatitis: a tale of two "hits"? Gastroenterology 114 842 845 10.1016/S0016-5085(98)70599-2 1:STN:280: DyaK1c3htFartQ%3D%3D 9547102 (Pubitemid 28160420)
41. M Duvnjak I Lerotic N Barsic V Tomasic L Virovic Jukic V Velagic 2007 Pathogenesis and management issues for non-alcoholic fatty liver disease World J Gastroenterol 13 4539 4550 1:CAS:528:DC%2BD2sXhtFGksLfL 17729403
42. TK Lam G van de Werve A Giacca 2003 Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites Am J Physiol Endocrinol Metab 284 E281 E290 1:CAS:528:DC%2BD3sXhtlGhtLY%3D 12531742
43. S Tamura I Shimomura 2005 Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease J Clin Invest 115 1139 1142 10.1172/JCI200524930 1:CAS:528:DC%2BD2MXktFSktr0%3D 15864343 (Pubitemid 40629030)
44. R Dentin JP Pegorier F Benhamed F Foufelle P Ferre V Fauveau, et al. 2004 Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression J Biol Chem 279 20314 20326 10.1074/jbc.M312475200 1:CAS:528:DC%2BD2cXjs1Whu7Y%3D 14985368 (Pubitemid 38623477)
45. K Iizuka RK Bruick G Liang JD Horton K Uyeda 2004 Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis Proc Natl Acad Sci USA 101 7281 7286 10.1073/pnas.0401516101 1:CAS:528:DC%2BD2cXksFaks7o%3D 15118080 (Pubitemid 38638024)
46. C Taghibiglou A Carpentier SC Van Iderstine B Chen D Rudy A Aiton, et al. 2000 Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model J Biol Chem 275 8416 8425 10.1074/jbc.275.12.8416 1:CAS:528:DC%2BD3cXit1entbg%3D 10722675 (Pubitemid 30180185)
47. M Charlton R Sreekumar D Rasmussen K Lindor KS Nair 2002 Apolipoprotein synthesis in nonalcoholic steatohepatitis Hepatology 35 898 904 10.1053/jhep.2002.32527 1:CAS:528:DC%2BD38XjtFSksLg%3D 11915037 (Pubitemid 34258385)
48. K Begriche A Igoudjil D Pessayre B Fromenty 2006 Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it Mitochondrion 6 1 28 10.1016/j.mito.2005.10.004 1:CAS:528:DC%2BD28XhsFyru7k%3D 16406828 (Pubitemid 43250588)
49. G Quash G Fournet U Reichert 2003 Anaplerotic reactions in tumour proliferation and apoptosis Biochem Pharmacol 66 365 370 10.1016/S0006-2952(03) 00106-0 1:CAS:528:DC%2BD3sXlvFygsbc%3D 12907234 (Pubitemid 36937020)
50. AJ Sanyal C Campbell-Sargent F Mirshahi WB Rizzo MJ Contos RK Sterling, et al. 2001 Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities Gastroenterology 120 1183 1192 10.1053/gast.2001. 23256 1:CAS:528:DC%2BD3MXjtVeqsb8%3D 11266382
51. SH Caldwell RH Swerdlow EM Khan JC Iezzoni EE Hespenheide JK Parks, et al. 1999 Mitochondrial abnormalities in non-alcoholic steatohepatitis J Hepatol 31 430 434 10.1016/S0168-8278(99)80033-6 1:CAS:528:DyaK1MXmtFKnsr4%3D 10488700 (Pubitemid 29408724)
52. B Fromenty MA Robin A Igoudjil A Mansouri D Pessayre 2004 The ins and outs of mitochondrial dysfunction in NASH Diabetes Metab 30 121 138 10.1016/S1262-3636(07)70098-8 1:CAS:528:DC%2BD2cXltlKht7Y%3D 15223984
53. A Kapoor AJ Sanyal 2009 Endoplasmic reticulum stress and the unfolded protein response Clin Liver Dis 13 581 590 10.1016/j.cld.2009.07.004 19818306
54. D Cai M Yuan DF Frantz PA Melendez L Hansen J Lee, et al. 2005 Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB Nat Med 11 183 190 10.1038/nm1166 1:CAS:528:DC%2BD2MXpvF2ntQ%3D%3D 15685173 (Pubitemid 40321354)
55. F Marra C Bertolani 2009 Adipokines in liver diseases Hepatology 50 957 969 10.1002/hep.23046 1:CAS:528:DC%2BD1MXhtFKntL3P 19585655
56. MH Jarrar A Baranova R Collantes B Ranard M Stepanova C Bennett, et al. 2008 Adipokines and cytokines in non-alcoholic fatty liver disease Aliment Pharmacol Ther 27 412 421 1:CAS:528:DC%2BD1cXjt1Wntb8%3D 18081738
57. A Watanabe A Hashmi DA Gomes T Town A Badou RA Flavell, et al. 2007 Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll-like receptor 9 Hepatology 46 1509 1518 10.1002/hep.21867 1:CAS:528: DC%2BD2sXhtlOiu7bL 17705260 (Pubitemid 350155533)
58. YH Paik RF Schwabe R Bataller MP Russo C Jobin DA Brenner 2003 Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells Hepatology 37 1043 1055 10.1053/jhep.2003.50182 1:CAS:528:DC%2BD3sXktVWns7Y%3D 12717385 (Pubitemid 36538681)
59. KM Utzschneider SE Kahn 2006 Review: the role of insulin resistance in nonalcoholic fatty liver disease J Clin Endocrinol Metab 91 4753 4761 10.1210/jc.2006-0587 1:CAS:528:DC%2BD28XhtlGru77J 16968800
60. M Manco M Marcellini G Giannone V Nobili 2007 Correlation of serum TNF-alpha levels and histologic liver injury scores in pediatric nonalcoholic fatty liver disease Am J Clin Pathol 127 954 960 10.1309/6VJ4DWGYDU0XYJ8Q 1:CAS:528:DC%2BD2sXntVCntbk%3D 17509993
61. A Wieckowska NN Zein LM Yerian AR Lopez AJ McCullough AE Feldstein 2006 In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease Hepatology 44 27 33 10.1002/hep.21223 1:CAS:528:DC%2BD28XnsFWjtrs%3D 16799979 (Pubitemid 44049136)
62. DL Diab L Yerian P Schauer SR Kashyap R Lopez SL Hazen, et al. 2008 Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients Clin Gastroenterol Hepatol 6 1249 1254 10.1016/j.cgh.2008.07.016 1:CAS:528:DC%2BD1MXms1ek 18995215
63. CT Wai JK Greenson RJ Fontana JD Kalbfleisch JA Marrero HS Conjeevaram, et al. 2003 A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C Hepatology 38 518 526 10.1053/jhep.2003.50346 12883497 (Pubitemid 36919874)
64. X Forns S Ampurdanes JM Llovet J Aponte L Quinto E Martinez-Bauer, et al. 2002 Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model Hepatology 36 986 992 12297848
65. J Guechot A Laudat A Loria L Serfaty R Poupon J Giboudeau 1996 Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis Clin Chem 42 558 563 1:CAS:528:DyaK28Xit1Onur0%3D 8605673
66. JL Hartley RM Brown A Tybulewicz P Hayes DC Wilson P Gillett, et al. 2006 Hyaluronic acid predicts hepatic fibrosis in children with hepatic disease J Pediatr Gastroenterol Nutr 43 217 221 10.1097/01.mpg.0000228121.44606.9f 1:CAS:528:DC%2BD28XnsVOks7s%3D 16877988 (Pubitemid 44180508)
67. P Cales F Oberti S Michalak I Hubert-Fouchard MC Rousselet A Konate, et al. 2005 A novel panel of blood markers to assess the degree of liver fibrosis Hepatology 42 1373 1381 10.1002/hep.20935 16317693 (Pubitemid 43260040)
68. F Imbert-Bismut V Ratziu L Pieroni F Charlotte Y Benhamou T Poynard 2001 Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study Lancet 357 1069 1075 10.1016/S0140-6736(00)04258- 6 1:CAS:528:DC%2BD3MXislGns70%3D 11297957 (Pubitemid 32322537)
69. LA Adams M Bulsara E Rossi B DeBoer D Speers J George, et al. 2005 Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection Clin Chem 51 1867 1873 10.1373/clinchem.2005.048389 1:CAS:528:DC%2BD2MXhtVGmtbrL 16055434 (Pubitemid 41368177)
70. V Nobili J Parkes G Bottazzo M Marcellini R Cross D Newman, et al. 2009 Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease Gastroenterology 136 160 167 10.1053/j.gastro.2008.09.013 1:CAS:528:DC%2BD1MXht1CqsrY%3D 18992746
71. P Angulo JM Hui G Marchesini E Bugianesi J George GC Farrell, et al. 2007 The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD Hepatology 45 846 854 10.1002/hep.21496 1:CAS:528:DC%2BD2sXltlWis7k%3D 17393509 (Pubitemid 46631552)
72. SA Harrison D Oliver HL Arnold S Gogia BA Neuschwander-Tetri 2008 Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease Gut 57 1441 1447 10.1136/gut.2007.146019 1:STN:280:DC%2BD1crpvF2isA%3D%3D 18390575
73. JB Dixon PS Bhathal PE O'Brien 2001 Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese Gastroenterology 121 91 100 10.1053/gast.2001.25540 1:CAS:528: DC%2BD3MXlt1ykt70%3D 11438497
74. Poynard T, Ratziu V, Charlotte F, Messous D, Munteanu M, Imbert-Bismut F, et al. Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol 2006;6:34
75. NA Palekar R Naus SP Larson J Ward SA Harrison 2006 Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease Liver Int 26 151 156 10.1111/j.1478-3231. 2005.01209.x 16448452
76. V Nobili F Vizzutti U Arena JG Abraldes F Marra A Pietrobattista, et al. 2008 Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis Hepatology 48 442 448 10.1002/hep.22376 1:CAS:528:DC%2BD1cXhtVCqt7rN 18563842
77. M Fraquelli C Rigamonti G Casazza D Conte MF Donato G Ronchi, et al. 2007 Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease Gut 56 968 973 10.1136/gut.2006.111302 17255218 (Pubitemid 46999083)
78. ND Manton J Lipsett DJ Moore GP Davidson AJ Bourne RT Couper 2000 Non-alcoholic steatohepatitis in children and adolescents Med J Aust 173 476 479 1:STN:280:DC%2BD3M7htlCrtw%3D%3D 11149304
79. P Vajro A Fontanella C Perna G Orso M Tedesco A De Vincenzo 1994 Persistent hyperaminotransferasemia resolving after weight reduction in obese children J Pediatr 125 239 241 10.1016/S0022-3476(94)70202-0 1:STN:280:DyaK2czhsFCquw%3D%3D 8040771 (Pubitemid 24253007)
80. V Nobili M Marcellini R Devito P Ciampalini F Piemonte D Comparcola, et al. 2006 NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice Hepatology 44 458 465 10.1002/hep.21262 16871574 (Pubitemid 44214885)
81. JE Lavine 2000 Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study J Pediatr 136 734 738 10.1067/mpd.2000.106566 1:CAS:528:DC%2BD3cXkslyns74%3D 10839868
82. P Vajro C Mandato A Franzese E Ciccimarra S Lucariello M Savoia, et al. 2004 Vitamin E treatment in pediatric obesity-related liver disease: a randomized study J Pediatr Gastroenterol Nutr 38 48 55 10.1097/00005176- 200401000-00012 1:CAS:528:DC%2BD3sXpvVShtL0%3D 14676594 (Pubitemid 39274467)
83. V Nobili M Manco R Devito P Ciampalini F Piemonte M Marcellini 2006 Effect of vitamin E on aminotransferase levels and insulin resistance in children with non-alcoholic fatty liver disease Aliment Pharmacol Ther 24 1553 1561 10.1111/j.1365-2036.2006.03161.x 1:CAS:528:DC%2BD2sXpslaitQ%3D%3D 17206944
84. P Vajro A Franzese G Valerio MP Iannucci N Aragione 2000 Lack of efficacy of ursodeoxycholic acid for the treatment of liver abnormalities in obese children J Pediatr 136 739 743 10.1067/mpd.2000.106565 1:CAS:528: DC%2BD3cXkslyns78%3D 10839869
85. JB Schwimmer MS Middleton R Deutsch JE Lavine 2005 A phase 2 clinical trial of metformin as a treatment for non-diabetic paediatric non-alcoholic steatohepatitis Aliment Pharmacol Ther 21 871 879 10.1111/j.1365-2036.2005. 02420.x 1:CAS:528:DC%2BD2MXjvVykt7g%3D 15801922 (Pubitemid 40477247)
86. KJ Nadeau LB Ehlers PS Zeitler K Love-Osborne 2009 Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents Pediatr Diabetes 10 5 13 10.1111/j.1399-5448. 2008.00450.x 1:CAS:528:DC%2BD1MXjsVCnu7c%3D 18721166
87. L Tock WL Prado DA Caranti DM Cristofalo H Lederman M Fisberg, et al. 2006 Nonalcoholic fatty liver disease decrease in obese adolescents after multidisciplinary therapy Eur J Gastroenterol Hepatol 18 1241 1245 10.1097/01.meg.0000243872.86949.95 17099371
88. CL Wang L Liang JF Fu CC Zou F Hong JZ Xue JR Lu, et al. 2008 Effect of lifestyle intervention on non-alcoholic fatty liver disease in Chinese obese children World J Gastroenterol 14 1598 1602 10.3748/wjg.14.1598 1:CAS:528:DC%2BD1cXkslKrurs%3D 18330955
89. T Reinehr C Schmidt AM Toschke W Andler 2009 Lifestyle intervention in obese children with non-alcoholic fatty liver disease: 2-year follow-up study Arch Dis Child 94 437 442 10.1136/adc.2008.143594 1:STN:280: DC%2BD1MzlvFyltQ%3D%3D 19224892
90. V Nobili M Manco P Ciampalini A Alisi R Devito E Bugianesi, et al. 2008 Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study Clin Ther 30 1168 1176 10.1016/j.clinthera. 2008.06.012 1:CAS:528:DC%2BD1cXhtVWltLrO 18640473